Q1 2026 Management View "We delivered $194 million of first quarter revenue" with "15% reported revenue growth or 11% organic" and "160 basis points of adjusted operating margin expansion" (President, ...
The company anticipates a moderated outlook for ATF filtration in 2026 due to customer-specific timing dynamics, with a ...
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q1 CY2026 results topping the market’s revenue ...
First quarter revenue of $194 million, a year-over-year increase of 15% as reported and 11% organicGAAP EPS increased 50% year-over-year and ...
What Happened? Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 7.3% in the morning ...
The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 38 cents per share. The drug developer posted revenue of $194.3 million in the period, also surpassing ...
Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2026 financial results on Tuesday, May 5, 2026. The Company will issue a press release before the ...
NEW YORK (Reuters) -Repligen, a provider of drug manufacturing equipment, has approached Maravai LifeSciences Holdings, a vaccine capping reagent vendor that has a market value of about $2.5 billion, ...
Repligen Corporation (NASDAQ:RGEN) reported in-line earnings for its second quarter on Tuesday. The company posted second-quarter sales of $154.1 million, almost in line with the consensus estimate of ...
Avitide, a company that spun out of an Ivy League lab with a way to quickly and efficiently purify biologic drugs, is being acquired for $150 million by global bioprocessing vendor Repligen, which ...
First quarter revenue of $194 million, a year-over-year increase of 15% as reported and 11% organicGAAP EPS increased 50% year-over-year and adjusted EPS increased 23% year-over-yearReiterating FY26 ...
Good day, ladies and gentlemen, and welcome to Repligen Corporation's First Quarter 2026 Earnings Conference Call. My name is Samantha, and I will be your coordinator. [Operator Instructions] I will ...